from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0197/-

LFCtreatmentdescriptionclass of inhibitor

0.198

Amikacinug/mL Amikacintranslation

-0.412

Cap5-10ug/mL Capreomycintranslation

0.403

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.996

Tet5-10 ug/mL Tetracyclinetranslation

-1.483

Rif0.2-5ug/mL Rifampicintranscription

-1.038

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.793

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.060

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.095

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.632

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.569

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.331

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.700

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.033

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.692

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.617

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.106

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.270

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.537

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.687

KCN5-20 ug/mL Potassium cyaniderespiration

-0.092

NaN30.2-2 mM Sodium aziderespiration

-0.628

Nigericin50 uM Nigericinrespiration

-0.702

TRC10-150 ug/mL Triclosanrespiration

1.139

TRZ10-25 ug/mL Thioridazinerespiration

2.300

Valinomycin0.5-10 uM Valinomycinrespiration

0.616

ZnSO42 mM ZnSO4respiration

2.146

menadione6-10 ug/mL Menadionerespiration

-0.102

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.050

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.296

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.063

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.462

NRP_1Non-replicating persistence stage 1dosRassociated

-0.507

Amp0.2mg/mL AmpicillincellWall

-0.460

Cephalexin20-100 ug/mL CephalexincellWall

0.263

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.199

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.630

EMB10-20 ug/mL EthambutolcellWall

-0.663

Eta12-40 ug/mL EthionamidecellWall

-0.084

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.219

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.687

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.111

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.269

BZA0.12 mg/mL BenzamidearomaticAmides

0.758

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.453

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.446

H2O24 mM hydrogen peroxideDNAdamaging

-1.524

Levo10 ug/mL LevofloxacinDNAdamaging

-0.476

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.468

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.626

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.352

UVUV-irradiationDNAdamaging

0.485

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.579

Antimycin12.5-50 ug/mL Antimycin A?

-0.363

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.626

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.695

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.314

PA8240.2-2 ug/mL PA-824?

-0.009

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.272

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.365

Verapamil50 uM Verapamil?

-0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

0.141

methoxatin10-20 ug/mL Methoxatin?